All the component to take your product from DNA, through IND and clinical trials and to support your global commercial supply. This includes antibody discovery, cell line development, process development and cGMP manufacturing supported by extensive analytical capabilities.
State of the art microbial manufacturing facilities for fermentation recovery & purification development through to cGMP manufacturing for preclinical, clinical and commercial supply.
Drug product development and cGMP manufacturing of sterile biologicals in liquid and lyophilized forms at lab and large-scale.
Comprehensive biosimilar development capabilities from cell line development to commercial supply to help our partners provide patients access to the most advanced therapies available.
Our proprietary cell line development platform and highly efficient R&D workflows have set the stage for the development of a range of biosimilar candidates, with several in clinical trials up to stage III.
Our new brand represents our passion and dedication to innovation, we utilize the latest technology and cutting-edge...
Polpharma Biologics and the University of Warsaw have signed a cooperation agreement in an important step toward buil...
Read the full interview and find out more about Polpharma Biologics CDMO services, forward expansion and whether COVI...